Eficácia da terapia fonoaudiológica convencional associada à eletroestimulação neuromuscular na disfagia decorrente do tratamento de preservação de órgão em casos de tumores de cabeça e pescoço Efectiveness of conventional speech-language pathology therapy associated to electrical stimulation for dysphagia following organ preservation treatment for head and neck cancer

2019 ◽  
Author(s):  
Gisele Lourenço
Keyword(s):  
Head And Neck Cancer ◽  
Electrical Stimulation ◽  
Head And Neck ◽  
Neck Cancer ◽  
Organ Preservation ◽  
Speech Language Pathology ◽  
Language Pathology

The Speech-Language Pathologist's Role in Screening for Head and Neck Cancer

2012 ◽  
Vol 22 (1) ◽  
pp. 6-13
Author(s):  
Edie R. Hapner
Keyword(s):  
Head And Neck Cancer ◽  
Head And Neck ◽  
Neck Cancer ◽  
Healthcare Professionals ◽  
Screening Tool ◽  
Communication Disorders ◽  
Speech Language Pathology ◽  
Speech Language Pathologists ◽  
Cancer Screenings ◽  
Language Pathology

The American Speech-Language-Hearing Association (ASHA)'s Preferred Practice Patterns for the Profession of Speech-Language Pathology (ASHA, 2004) and Prevention of Communication Disorders (ASHA, 1988) advise speech-language pathologists to engage in activities to educate and prevent diseases and disorders that affect speech and swallowing. However, many speech-language pathologists may be unfamiliar with the use of head and neck cancer screening that can be easily integrated into oral mechanism examinations and perceptual voice evaluations. This paper reviews the problem created by the lack of knowledge and reduced risk perception by the general public and healthcare professionals regarding signs, symptoms, and risks for head and neck cancer. A simple six-step screening tool is included to aid the reader in integrating head and neck cancer screenings into a general oral mechanism and speech/voice evaluation.

Using Telepractice to Support the Management of Head and Neck Cancer: Key Considerations for Speech-Language Pathology Service Planning, Establishment, and Evaluation

2017 ◽  
Vol 2 (13) ◽  
pp. 139-146
Author(s):  
Clare L. Burns ◽  
Laurelie R. Wall
Keyword(s):  
Head And Neck Cancer ◽  
Head And Neck ◽  
Neck Cancer ◽  
Service Planning ◽  
Current Evidence ◽  
Speech Language Pathology ◽  
Staff Support ◽  
Clinical Patient ◽  
Research Reporting ◽  
Language Pathology

With the rise of technology-enhanced health services, there is a growing opportunity to use telepractice to address the challenges associated with accessing and delivering speech-language pathology head and neck cancer (HNC) services. With an emerging body of research reporting clinical, patient and service benefits, careful planning and coordination of a range of factors are required to integrate these new models into routine speech-language pathology practice. This paper provides a review of current evidence and key professional policy documents to assist clinicians in the development of speech-language pathology HNC telepractice services. Important aspects of service design such as mode and configuration of technology, patient suitability, staff support, and training, as well as strategies for service establishment and evaluation are discussed. Consideration of these aspects is important to ensure that future speech-language pathology HNC telepractice services meet clinical, technical, and operational requirements to support successful service implementation and long-term sustainability.

Daily concurrent chemoradiotherapy with docetaxel (DOC) and cisplatin (CDDP) using superselective intra-arterial infusion via superficial temporal artery for T3 and T4 head and neck cancer: Possibility of organ preservation in advanced head and neck cancer

2009 ◽  
Vol 27 (15_suppl) ◽  
pp. e17020-e17020
Author(s):  
K. Mitsudo ◽  
T. Shigetomi ◽  
H. Nishiguchi ◽  
T. Fukui ◽  
N. Yamamoto ◽  
...  
Keyword(s):  
Head And Neck Cancer ◽  
Lymph Node ◽  
Head And Neck ◽  
Neck Cancer ◽  
Organ Preservation ◽  
Cervical Lymph Node ◽  
Superficial Temporal Artery ◽  
Temporal Artery ◽  
Advanced Head ◽  
Concurrent Radiotherapy

e17020 Background: Superselective intra-arterial chemotherapy via a superficial temporal artery (HFT method) has become feasible for daily concurrent radiotherapy and chemotherapy for head and neck cancer. We used this novel method for head and neck cancer, and evaluated its efficacy. Treatment consisted of superselective intra-arterial infusions (docetaxel total 60 mg/m2, cisplatin total 100 mg/m2) and concurrent radiotherapy (total 40 Gy) for 4 weeks as preoperative therapy. Thirty-five patients with stage III and IV oral cancer underwent surgery after this treatment, of whom pathological complete response (CR) was obtained in 31 (88.6%). In this study, the possibility of organ preservation in cases of advanced head and neck cancer was evaluated based on this result. Methods: Eligibility included T3 or T4 squamous cell carcinoma of head and neck. Treatment consisted of superselective intra-arterial infusions (docetaxel, total 60 mg/m2, cisplatin, total 150 mg/m2) and concurrent radiotherapy (total 60 Gy) for 6 weeks. Organ preservation was demonstrated in cases when the biopsy specimen of the primary lesion showed grade 3 (non-viable tumor cells present) or grade 4 (no tumor cells present) after the completion of all treatments. Results: Thirty two patients (21 male and 11 female) were eligible for evaluation. A relapse was detected in 11 cases (34.4%): primary sites, 7 cases (21.9%); cervical lymph node and distant metastasis, 2 cases (6.3%); primary site and distant metastasis, 1 case (3.1%); cervical lymph node, 1 case (3.1%). Seven patients (21.9%) died. The Kaplan-Meier method was used to estimate the 3-year and 5-year survival rates, which were 81.3% and 78.1%, respectively, and the 3-year and 5-year locoregional control rates, which were 68.8% and 64.5%, respectively. No major complications such as cerebral infarctions or other neurological complications developed in any patient. Conclusions: These results of the present study demonstrate that this is a promising new treatment strategy for advanced head and neck cancer, thus contributing to patients’ QOL. No significant financial relationships to disclose.

scholarly journals Salvage Surgery in Head and Neck Cancer

2021 ◽  
pp. 233-246
Author(s):  
Stijn van Weert ◽  
Sat Parmar ◽  
C. René Leemans
Keyword(s):  
Head And Neck Cancer ◽  
Head And Neck ◽  
Neck Cancer ◽  
Organ Preservation ◽  
Salvage Surgery ◽  
Transoral Robotic Surgery ◽  
Shared Decision ◽  
Surgery Complications

AbstractSalvage surgery (SS) in head and neck cancer is considered a last resort treatment after failure of organ preservation treatments. It offers challenges to the patients and the surgeon. The outcome of SS is often uncertain in terms of survival and quality of life. This paper offers an overview of evolution in SS, tumor and patient factors to be considered, challenges in reconstructive surgery, complications of SS and the changing landscape with regard to increasing incidence of human papillomavirus positive tumours, the role of transoral robotic surgery, the importance of multidisciplinary management and shared decision making.

Sign in / Sign up

Export Citation Format

Share Document